Home › Novartis works with Bristol-Myers for lung cancer studies
 

Keywords :   


Novartis works with Bristol-Myers for lung cancer studies

2014-10-06 15:29:56| Biotech - Topix.net

Swiss pharma group Novartis AG said on Monday it had entered into a clinical collaboration with Bristol-Myers Squibb Co to evaluate the safety and efficacy of combination treatments for patients with non-small cell lung cancer. The collaboration will help Novartis further advance its efforts in the field of immunotherapy, following the acquisition of CoStim Pharmaceuticals Inc this year, Novartis said in a statement.

Tags: works studies cancer lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07Atlantic Tropical Weather Outlook
02.07Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 16A
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Eastern North Pacific Tropical Weather Outlook
02.07Automotive Coatings to Reach $19B by 2028: MarketsandMarkets
More »